| P50 | author | David M Koelle | Q40734874 |
| | Ioannis Gavvovidis | Q54836861 |
| P2093 | author name string | David Crispin | |
| | Paul Nghiem | |
| | Martin McIntosh | |
| | Matthew P Fitzgibbon | |
| | Thomas Blankenstein | |
| | Lichun Dong | |
| | Lichen Jing | |
| | Natalie J Miller | |
| | Gerald Willimsky | |
| | Kristina Lachance | |
| | Michi Shinohara | |
| | Candice D Church | |
| P2860 | cites work | Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen | Q24623215 |
| | Clonal integration of a polyomavirus in human Merkel cell carcinoma | Q24657675 |
| | PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma. | Q27853379 |
| | Merkel cell carcinoma: prognosis and treatment of patients from a single institution | Q28242597 |
| | Different T Cell Receptor Affinity Thresholds and CD8 Coreceptor Dependence Govern Cytotoxic T Lymphocyte Activation and Tetramer Binding Properties | Q57372665 |
| | Limit-dilution assay and clonal expansion of all T cells capable of proliferation | Q72116017 |
| | Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity | Q74292770 |
| | PD-1 blockade induces responses by inhibiting adaptive immune resistance | Q29620856 |
| | TCR-ligand koff rate correlates with the protective capacity of antigen-specific CD8+ T cells for adoptive transfer | Q30576352 |
| | Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens | Q33966574 |
| | PANDAseq: paired-end assembler for illumina sequences | Q34158516 |
| | Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system | Q34208807 |
| | CD8+ lymphocyte intratumoral infiltration as a stage-independent predictor of Merkel cell carcinoma survival: a population-based study. | Q34240920 |
| | Antibodies to Merkel Cell Polyomavirus T Antigen Oncoproteins Reflect Tumor Burden in Merkel Cell Carcinoma Patients | Q34267871 |
| | Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. | Q34866209 |
| | Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. | Q34985137 |
| | Linking T-cell receptor sequence to functional phenotype at the single-cell level | Q35111823 |
| | Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood. | Q35510910 |
| | Determinants of public T cell responses | Q35958856 |
| | Immune epitope database analysis resource | Q36088427 |
| | Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6 | Q36154471 |
| | Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus | Q36498051 |
| | Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. | Q36585604 |
| | Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage | Q36605019 |
| | Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions. | Q36633084 |
| | Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy | Q36653748 |
| | T cell receptor αβ diversity inversely correlates with pathogen-specific antibody levels in human cytomegalovirus infection | Q36672239 |
| | Merkel cell carcinoma: 30-year experience from a single institution | Q38064764 |
| | Emerging and mechanism-based therapies for recurrent or metastatic Merkel cell carcinoma | Q38084205 |
| | T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors | Q38871209 |
| | Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma | Q38966773 |
| | An intact retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells | Q39574886 |
| | High avidity antigen-specific CTL identified by CD8-independent tetramer staining | Q40618338 |
| | High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL. | Q40830770 |
| | High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy. | Q40978441 |
| | Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I | Q41866420 |
| | Tumor-infiltrating lymphocytes and outcome in Merkel cell carcinoma, a virus-associated cancer. | Q42214828 |
| | Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers | Q42278531 |
| | Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense | Q43604283 |
| | Prognostic factors in Merkel cell carcinoma: analysis of 240 cases | Q44269215 |
| | Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue | Q44788642 |
| | MiXCR: software for comprehensive adaptive immunity profiling. | Q48193977 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Merkel cell polyomavirus | Q1921796 |
| P304 | page(s) | 137-147 | |
| P577 | publication date | 2017-01-16 | |
| P1433 | published in | Cancer Immunology Research | Q26841983 |
| P1476 | title | Tumor-Infiltrating Merkel Cell Polyomavirus-Specific T Cells Are Diverse and Associated with Improved Patient Survival | |
| P478 | volume | 5 | |